Standard Operating Procedure for Handling Raw Materials for Nanoparticle Formulations

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to outline the steps for the proper receipt, identification, and storage of raw materials used in the preparation of nanoparticle-based formulations. It ensures that all materials are handled in a manner that prevents contamination and ensures the integrity and quality of the materials.

2) Scope

This SOP applies to all personnel involved in the handling of raw materials used for nanoparticle-based formulations. This includes operators, quality assurance (QA) staff, and warehouse personnel involved in the receiving, identification, and storage of raw materials.

3) Responsibilities

• Operators: Responsible for receiving and identifying the raw materials, and ensuring proper storage.
• Quality Assurance (QA): Responsible for verifying the materials meet required specifications and ensuring proper documentation is maintained.
• Warehouse Team: Responsible for the correct storage of raw materials, including temperature control and safety procedures.

4) Procedure

4.1 Raw Material Receipt

4.1.1 Inspection of Incoming Materials

• 4.1.1.1 Upon delivery, inspect the packaging of the materials for any visible signs of damage, contamination, or tampering.
• 4.1.1.2 Ensure that all packaging is intact and has the correct labeling in compliance with regulatory and company standards.
• 4.1.1.3 Compare the delivered items against the purchase order to ensure the correct quantities and materials are received.

4.1.2 Documentation of Receipt

• 4.1.2.1 Record the details of the received materials in the raw materials receipt and inspection logbook, noting the date, time of receipt, material name, batch number, and supplier details.
• 4.1.2.2 Ensure that any discrepancies between the received materials and the purchase order are documented and communicated to QA for further investigation.

4.2 Material Identification

4.2.1 Labeling

• 4.2.1.1 Once materials are received, ensure that each container is labeled with the material name, batch number, and the date of receipt.
• 4.2.1.2 Labels should be resistant to smudging and should be clearly visible on each container.

4.2.2 Sampling

• 4.2.2.1 Prior to use, samples of raw materials should be taken for quality control (QC) testing to ensure compliance with specifications.
• 4.2.2.2 Sampling should be conducted in a controlled environment to avoid contamination. Follow the company’s sampling SOP for nanoparticle raw materials.

4.3 Storage of Raw Materials

4.3.1 Storage Conditions

• 4.3.1.1 Store all raw materials in designated storage areas that are maintained at the required environmental conditions, such as temperature and humidity.
• 4.3.1.2 Temperature-sensitive materials should be stored in refrigerated or frozen storage as per their specific requirements. Monitor storage conditions regularly.

4.3.2 Stock Rotation

• 4.3.2.1 Implement a First-In-First-Out (FIFO) system to ensure older stock is used before newer stock.
• 4.3.2.2 Regularly inspect the stored materials for any signs of degradation, contamination, or expiration. Dispose of any materials that do not meet quality standards in accordance with company disposal procedures.

4.4 Safety Considerations

4.4.1 Personal Protective Equipment (PPE)

• 4.4.1.1 Operators handling raw materials must wear appropriate PPE, including gloves, masks, and protective clothing, to prevent contamination of the materials and ensure personal safety.
• 4.4.1.2 Follow all safety guidelines for handling hazardous or sensitive materials as per the material safety data sheet (MSDS) associated with each raw material.

4.4.2 Handling Procedures

• 4.4.2.1 Use appropriate equipment to handle large or heavy containers to prevent injury and spillage. Ensure that all raw materials are handled with care to avoid damage to the packaging or contamination of the product.
• 4.4.2.2 If any raw material spills occur, follow the company’s spill management SOP to contain and clean the spill immediately.

5) Abbreviations, if any

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• QC: Quality Control
• PPE: Personal Protective Equipment

6) Documents, if any

• Raw Material Receipt and Inspection Logbook

7) References, if any

• Good Manufacturing Practice (GMP) Guidelines for Pharmaceuticals
• ISO 9001:2015 Quality Management Systems Requirements

8) SOP Version

Version 1.0

Annexure

Raw Material Receipt and Inspection Logbook Template

  

    
Date
    
Material Name
    
Batch Number
    
Quantity Received
    
Supplier
    
Inspector Initials
    
Remarks
  
  

    
DD/MM/YYYY
    
Material Name
    
Batch Number
    
Quantity in kg
    
Supplier Name
    
Inspector Name
    
Inspection results and remarks
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Handling Nanoparticle Precursors

1) Purpose

This SOP outlines the procedures for the preparation and safe handling of nanoparticle precursors used in the production of nanoparticle formulations. The objective is to ensure proper preparation, safe handling, and prevention of contamination.

2) Scope

This SOP applies to all laboratory staff and operators who are responsible for the preparation and handling of nanoparticle precursors within the laboratory and production areas.

3) Responsibilities

• Operators: Responsible for handling and preparing nanoparticle precursors in compliance with this SOP.
• QA: Ensures quality of the prepared precursors and compliance with safety guidelines.

4) Procedure

4.1 Preparation of Nanoparticle Precursors

4.1.1 Required Materials

• 4.1.1.1 Gather all required precursor materials, such as polymers, surfactants, lipids, or metals, depending on the nanoparticle type.
• 4.1.1.2 Ensure all equipment and containers are cleaned and sanitized according to laboratory guidelines.

4.1.2 Weighing and Dispensing

• 4.1.2.1 Use a calibrated balance to weigh the exact amounts of precursors as per the formulation batch record.
• 4.1.2.2 Dispense the required materials into properly labeled containers for each batch.

4.2 Handling of Precursors

4.2.1 Safety Measures

• 4.2.1.1 Ensure all operators are wearing appropriate personal protective equipment (PPE), including gloves, safety goggles, and lab coats.
• 4.2.1.2 Work in a fume hood or well-ventilated area when handling volatile or hazardous chemicals.

4.2.2 Contamination Prevention

• 4.2.2.1 Use sterile, sealed containers to transport precursors to the production area to prevent cross-contamination.
• 4.2.2.2 Handle precursors only with sterilized tools to avoid contamination.

4.3 Storage of Nanoparticle Precursors

4.3.1 Storage Conditions

• 4.3.1.1 Store all nanoparticle precursors at the appropriate temperature (as indicated in the precursor’s material safety data sheet) to maintain stability and prevent degradation.
• 4.3.1.2 Ensure all containers are labeled with material name, batch number, and date of preparation.

5) Abbreviations, if any

• PPE: Personal Protective Equipment
• QA: Quality Assurance

6) Documents, if any

• Nanoparticle Precursor Preparation Logbook

7) References, if any

• Material Safety Data Sheets (MSDS) for nanoparticle precursors

8) SOP Version

Version 1.0

Annexure

Nanoparticle Precursor Preparation Logbook Template

  

    
Date
    
Material Name
    
Batch Number
    
Quantity Prepared
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Precursor Material
    
Batch Number
    
Quantity in grams
    
Operator Name
    
QA Name
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Solvent Selection and Preparation for Nanoparticles

1) Purpose

This SOP provides a detailed guideline for selecting, handling, and preparing solvents used in the synthesis of nanoparticle formulations. This ensures the correct solvent is chosen for the desired nanoparticle properties and that solvents are handled safely.

2) Scope

This SOP applies to all staff involved in the preparation, selection, and handling of solvents for nanoparticle synthesis.

3) Responsibilities

• Operators: Ensure the correct solvent is chosen, prepared, and handled according to this SOP.
• QA: Verify that solvent handling procedures are compliant with safety and quality standards.

4) Procedure

4.1 Solvent Selection

4.1.1 Criteria for Solvent Selection

• 4.1.1.1 The solvent should be chosen based on the chemical properties of the precursor materials and the required characteristics of the nanoparticle product (e.g., size, stability).
• 4.1.1.2 Choose solvents with high purity and low volatility unless otherwise specified for specific nanoparticle synthesis processes.

4.2 Solvent Preparation

4.2.1 Solvent Handling

• 4.2.1.1 Always handle solvents in a fume hood or well-ventilated area to minimize exposure to fumes.
• 4.2.1.2 Ensure all containers are properly labeled with the solvent name, concentration, and preparation date.

4.2.2 Solvent Dispensing

• 4.2.2.1 Dispense the required amount of solvent using calibrated equipment (e.g., pipettes or volumetric flasks) to ensure accuracy in formulation.
• 4.2.2.2 Avoid spillage by using appropriate funnels and sealed containers during solvent transfer.

5) Abbreviations, if any

• PPE: Personal Protective Equipment
• QA: Quality Assurance

6) Documents, if any

• Solvent Preparation Logbook

7) References, if any

• MSDS for solvents

8) SOP Version

Version 1.0

Annexure

Solvent Preparation Logbook Template

  

    
Date
    
Solvent Name
    
Concentration
    
Volume Prepared
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Solvent Name
    
Concentration %
    
Volume in mL
    
Operator Name
    
QA Name
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Weighing and Dispensing Raw Materials

1) Purpose

This SOP outlines the procedures for accurately weighing and dispensing raw materials used in nanoparticle formulations. The aim is to ensure the correct quantities are measured and handled safely to avoid contamination or errors in formulation.

2) Scope

This SOP applies to all operators and staff involved in the weighing and dispensing of raw materials in the production of nanoparticle formulations.

3) Responsibilities

• Operators: Responsible for weighing and dispensing raw materials accurately according to the batch record or formulation guidelines.
• QA: Ensures that weighing and dispensing procedures follow established standards and quality protocols.

4) Procedure

4.1 Equipment Setup

4.1.1 Calibration of Weighing Equipment

• 4.1.1.1 Ensure that all weighing scales are calibrated before use. Calibration records must be checked and updated before weighing any materials.
• 4.1.1.2 Use appropriate calibration weights as per the equipment manufacturer’s guidelines.

4.1.2 Cleaning of Equipment

• 4.1.2.1 Clean all weighing surfaces, containers, and tools before use to avoid cross-contamination.
• 4.1.2.2 Ensure the work area is free from any previous materials or residues that could interfere with the current batch.

4.2 Weighing Procedure

4.2.1 Weighing of Raw Materials

• 4.2.1.1 Carefully weigh each raw material according to the quantities specified in the batch record. Always use a clean, dry container for each material.
• 4.2.1.2 Record the weight of each material in the raw material weighing logbook, ensuring it matches the required quantity.
• 4.2.1.3 If there is any deviation in weight, document and report it to the supervisor or QA for review.

4.2.2 Dispensing Raw Materials

• 4.2.2.1 After weighing, dispense the raw materials into clearly labeled containers for each stage of the formulation process.
• 4.2.2.2 Ensure that all containers are sealed and transported properly to prevent spillage or contamination.

4.3 Safety Considerations

4.3.1 Personal Protective Equipment (PPE)

• 4.3.1.1 All operators must wear appropriate PPE, including gloves, masks, and lab coats, to prevent contamination and ensure personal safety.

4.3.2 Handling Hazardous Materials

• 4.3.2.1 For any hazardous or volatile materials, handle them inside a fume hood or well-ventilated area and follow all safety guidelines as per the MSDS.

5) Abbreviations, if any

• PPE: Personal Protective Equipment
• QA: Quality Assurance
• MSDS: Material Safety Data Sheet

6) Documents, if any

• Raw Material Weighing Logbook

7) References, if any

• Good Manufacturing Practice (GMP) Guidelines for Pharmaceuticals
• MSDS for raw materials

8) SOP Version

Version 1.0

Annexure

Raw Material Weighing Logbook Template

  

    
Date
    
Material Name
    
Batch Number
    
Weight Dispensed
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Material Name
    
Batch Number
    
Weight in grams
    
Operator Name
    
QA Name
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Lipid-Based Nanoparticle Preparation

1) Purpose

This SOP outlines the process for preparing lipid-based nanoparticles (LNPs), which are commonly used for drug delivery systems. The objective is to standardize the preparation process, ensuring consistency and quality in the formulation.

2) Scope

This SOP applies to all operators involved in the preparation and formulation of lipid-based nanoparticles in the laboratory or production environment.

3) Responsibilities

• Operators: Responsible for following the SOP to prepare lipid-based nanoparticles accurately and safely.
• QA: Ensures that LNP preparation follows approved protocols and meets quality standards.

4) Procedure

4.1 Preparation of Lipid Solutions

4.1.1 Materials and Equipment

• 4.1.1.1 Prepare all lipid components, including phospholipids, cholesterol, and surfactants, as required by the formulation.
• 4.1.1.2 Ensure that all equipment (e.g., homogenizer, mixer) is cleaned and sanitized.

4.1.2 Solubilization of Lipids

• 4.1.2.1 Dissolve the lipid components in an organic solvent (e.g., ethanol) under gentle stirring.
• 4.1.2.2 Heat the solution slightly (if necessary) to ensure complete solubilization, but do not exceed the lipid stability limits.

4.2 Nanoparticle Formation

4.2.1 Emulsification

• 4.2.1.1 Slowly inject the lipid solution into an aqueous phase containing stabilizers or surfactants under high-speed mixing to form a stable emulsion.
• 4.2.1.2 Continue mixing for 10-15 minutes to ensure proper emulsification.

4.2.2 Particle Size Reduction

• 4.2.2.1 Use a high-pressure homogenizer or sonicator to reduce the particle size to the desired range (typically 100-200 nm).
• 4.2.2.2 Monitor the particle size using dynamic light scattering (DLS) or a similar technique.

4.3 Storage and Stability

4.3.1 Storage Conditions

• 4.3.1.1 Transfer the lipid-based nanoparticles into sterile, sealed containers for storage.
• 4.3.1.2 Store at 4°C or lower to maintain stability unless otherwise specified for the formulation.

4.3.2 Stability Testing

• 4.3.2.1 Periodically test the LNP formulations for particle size, encapsulation efficiency, and zeta potential to ensure stability over time.

5) Abbreviations, if any

• LNP: Lipid-Based Nanoparticle
• DLS: Dynamic Light Scattering

6) Documents, if any

• Lipid-Based Nanoparticle Preparation Logbook

7) References, if any

• Formulation protocols for lipid-based nanoparticles

8) SOP Version

Version 1.0

Annexure

Lipid-Based Nanoparticle Preparation Logbook Template

  

    
Date
    
Batch Number
    
Formulation
    
Particle Size
    
Encapsulation Efficiency
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Batch Number
    
Formulation Code
    
Size in nm
    
% Encapsulation
    
Operator Name
    
QA Name
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Preparation of Polymer-Based Nanoparticles

1) Purpose

This SOP describes the process for preparing polymer-based nanoparticles, commonly used for drug delivery and other biomedical applications. It aims to ensure a consistent and high-quality preparation process.

2) Scope

This SOP applies to laboratory personnel involved in the preparation and processing of polymer-based nanoparticles in the research or production setting.

3) Responsibilities

• Operators: Responsible for the accurate preparation and processing of polymer-based nanoparticles according to this SOP.
• QA: Ensures compliance with protocols and verifies the quality of prepared nanoparticles.

4) Procedure

4.1 Polymer Preparation

4.1.1 Polymer Selection

• 4.1.1.1 Select appropriate polymers (e.g., PLGA, PEG) based on the desired properties of the nanoparticles (e.g., size, degradation rate).
• 4.1.1.2 Verify the quality of the polymer by reviewing certificates of analysis and performing any necessary pre-processing checks.

4.1.2 Polymer Dissolution

• 4.1.2.1 Dissolve the polymer in an appropriate solvent (e.g., acetone or ethanol) under continuous stirring until fully solubilized.
• 4.1.2.2 If heating is required, ensure the temperature does not exceed the polymer’s thermal stability.

4.2 Nanoparticle Formation

4.2.1 Emulsification

• 4.2.1.1 Slowly add the polymer solution to an aqueous phase containing stabilizers under high-speed homogenization to form an emulsion.
• 4.2.1.2 Continue mixing for 10–15 minutes to stabilize the emulsion.

4.2.2 Solvent Evaporation

• 4.2.2.1 Allow the solvent to evaporate under reduced pressure or by stirring at room temperature, leading to nanoparticle formation as the polymer precipitates.
• 4.2.2.2 Monitor particle size using dynamic light scattering (DLS) or other particle-sizing methods.

4.3 Collection and Washing of Nanoparticles

4.3.1 Centrifugation

• 4.3.1.1 Centrifuge the nanoparticle suspension at 10,000–20,000 g for 20–30 minutes to collect the nanoparticles.
• 4.3.1.2 Discard the supernatant and wash the nanoparticles by resuspending them in distilled water and repeating the centrifugation process.

4.4 Storage of Nanoparticles

4.4.1 Storage Conditions

• 4.4.1.1 Store the polymer-based nanoparticles in sterile, sealed containers at 4°C or freeze them for long-term storage, depending on the stability of the formulation.

5) Abbreviations, if any

• DLS: Dynamic Light Scattering
• PLGA: Poly(lactic-co-glycolic acid)
• PEG: Polyethylene glycol
• PPE: Personal Protective Equipment

6) Documents, if any

• Polymer-Based Nanoparticle Preparation Logbook

7) References, if any

• Polymer Material Safety Data Sheets (MSDS)

8) SOP Version

Version 1.0

Annexure

Polymer-Based Nanoparticle Preparation Logbook Template

  

    
Date
    
Batch Number
    
Polymer Type
    
Particle Size
    
Encapsulation Efficiency
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Batch Number
    
Polymer Name
    
Size in nm
    
% Encapsulation
    
Operator Name
    
QA Name
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Surfactant Use in Nanoparticle Formulations

1) Purpose

This SOP provides guidelines for the appropriate selection, handling, and use of surfactants in nanoparticle formulations to ensure proper stabilization of particles and consistency in product quality.

2) Scope

This SOP applies to all laboratory staff involved in the preparation of nanoparticle formulations requiring surfactants for stabilization or formulation purposes.

3) Responsibilities

• Operators: Responsible for the proper selection and use of surfactants in nanoparticle formulations.
• QA: Ensures surfactant usage complies with the formulation protocol and meets quality standards.

4) Procedure

4.1 Selection of Surfactants

4.1.1 Criteria for Surfactant Selection

• 4.1.1.1 Select surfactants based on their compatibility with the nanoparticle material, type of formulation, and intended application (e.g., Tween 80, SDS).
• 4.1.1.2 Review the Material Safety Data Sheets (MSDS) for each surfactant to ensure safe handling and usage.

4.2 Surfactant Handling

4.2.1 Weighing and Dispensing

• 4.2.1.1 Accurately weigh the required amount of surfactant using a calibrated balance, as per the formulation guidelines.
• 4.2.1.2 Dispense the surfactant into clean, labeled containers for use in the formulation.

4.2.2 Solubilization of Surfactants

• 4.2.2.1 Dissolve the surfactant in water or the relevant solvent under gentle stirring to ensure proper solubilization before adding it to the nanoparticle formulation.
• 4.2.2.2 Ensure the temperature does not exceed the stability limits of the surfactant during solubilization.

4.3 Addition of Surfactants to Nanoparticle Formulations

4.3.1 Incorporation of Surfactants

• 4.3.1.1 Add the dissolved surfactant slowly into the nanoparticle formulation under continuous stirring to avoid clumping or aggregation.
• 4.3.1.2 Continue stirring for at least 15–30 minutes to ensure uniform distribution of the surfactant throughout the formulation.

4.4 Safety and Handling

4.4.1 Safety Guidelines

• 4.4.1.1 Wear appropriate PPE, including gloves, goggles, and lab coats, when handling surfactants.
• 4.4.1.2 Work in a fume hood or well-ventilated area if the surfactant is volatile or hazardous.

5) Abbreviations, if any

• SDS: Sodium Dodecyl Sulfate
• PPE: Personal Protective Equipment

6) Documents, if any

• Surfactant Usage Logbook

7) References, if any

• MSDS for surfactants

8) SOP Version

Version 1.0

Annexure

Surfactant Usage Logbook Template

  

    
Date
    
Surfactant Name
    
Batch Number
    
Amount Used
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Surfactant Name
    
Batch Number
    
Amount in grams
    
Operator Name
    
QA Name
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Nanoencapsulation Techniques

1) Purpose

This SOP outlines the standard procedures for performing nanoencapsulation techniques, commonly used in drug delivery systems to improve bioavailability and targeted delivery of pharmaceutical compounds.

2) Scope

This SOP applies to all laboratory personnel involved in the preparation of nanoencapsulated drug formulations.

3) Responsibilities

• Operators: Responsible for following the SOP to prepare nanoencapsulated drug formulations correctly.
• QA: Ensures compliance with the preparation protocols and verifies the quality of the final product.

4) Procedure

4.1 Material Preparation

4.1.1 Preparation of Drug Substance

• 4.1.1.1 Accurately weigh the drug substance using a calibrated balance.
• 4.1.1.2 Dissolve the drug in a suitable solvent based on the drug’s solubility characteristics.

4.1.2 Preparation of Encapsulation Matrix

• 4.1.2.1 Select an appropriate encapsulating material (e.g., polymer, lipid) based on the desired release profile and compatibility with the drug.
• 4.1.2.2 Dissolve the encapsulating material in an organic solvent or aqueous medium under stirring.

4.2 Encapsulation Techniques

4.2.1 Emulsification-Solvent Evaporation

• 4.2.1.1 Mix the drug solution with the encapsulating material under high-speed homogenization to form an emulsion.
• 4.2.1.2 Allow the solvent to evaporate, leading to the formation of nanoencapsulated particles as the polymer or lipid solidifies.

4.2.2 Nanoprecipitation

• 4.2.2.1 Add the drug-encapsulating material to a non-solvent under continuous stirring, causing the polymer or lipid to precipitate and encapsulate the drug.
• 4.2.2.2 Continue stirring until the nanoprecipitation process is complete and particles are formed.

4.3 Washing and Collection of Nanoparticles

4.3.1 Centrifugation

• 4.3.1.1 Centrifuge the nanoencapsulated particles to collect them, discarding the supernatant.
• 4.3.1.2 Wash the particles by resuspending them in distilled water and centrifuging again to remove any residual solvents.

4.4 Particle Size Analysis

4.4.1 Dynamic Light Scattering (DLS)

• 4.4.1.1 Use DLS or a similar technique to measure the particle size and distribution of the nanoencapsulated particles.
• 4.4.1.2 Record the average particle size and ensure it meets the desired specifications.

4.5 Storage

4.5.1 Storage Conditions

• 4.5.1.1 Transfer the nanoencapsulated drug formulations to sterile containers and store them at 4°C or lower, depending on the stability of the formulation.

5) Abbreviations, if any

• DLS: Dynamic Light Scattering
• QA: Quality Assurance

6) Documents, if any

• Nanoencapsulation Process Logbook

7) References, if any

• Relevant literature on nanoencapsulation techniques and their applications in drug delivery

8) SOP Version

Version 1.0

Annexure

Nanoencapsulation Process Logbook Template

  

    
Date
    
Batch Number
    
Encapsulation Technique
    
Particle Size
    
Encapsulation Efficiency
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Batch Number
    
Technique Used (e.g., Emulsification, Nanoprecipitation)
    
Size in nm
    
% Encapsulation
    
Operator Name
    
QA Name
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Preparation of Metal Nanoparticles

1) Purpose

This SOP describes the process for preparing metal nanoparticles, such as gold, silver, and iron oxide nanoparticles, for various applications, including drug delivery, catalysis, and biomedical imaging.

2) Scope

This SOP applies to all laboratory personnel involved in the synthesis and preparation of metal nanoparticles.

3) Responsibilities

• Operators: Responsible for following the SOP to prepare metal nanoparticles accurately and safely.
• QA: Ensures compliance with the preparation protocols and verifies the quality of the metal nanoparticles.

4) Procedure

4.1 Preparation of Metal Salt Solution

4.1.1 Selection of Metal Salt

• 4.1.1.1 Select a metal salt (e.g., gold chloride, silver nitrate) based on the desired metal nanoparticle.
• 4.1.1.2 Dissolve the metal salt in distilled water or another suitable solvent under gentle stirring.

4.2 Reduction Process

4.2.1 Reduction Using Chemical Reducing Agents

• 4.2.1.1 Add a reducing agent (e.g., sodium citrate, sodium borohydride) to the metal salt solution under constant stirring.
• 4.2.1.2 Continue stirring the solution until the reaction is complete and nanoparticles are formed, as indicated by a color change (e.g., gold nanoparticles produce a red/pink color).

4.2.2 Thermal or Photochemical Reduction

• 4.2.2.1 Alternatively, perform a thermal or photochemical reduction by exposing the metal salt solution to heat or UV light, leading to nanoparticle formation.

4.3 Stabilization of Nanoparticles

4.3.1 Use of Capping Agents

• 4.3.1.1 To stabilize the metal nanoparticles, add a capping agent (e.g., polyvinyl alcohol, thiols) to the solution.
• 4.3.1.2 Stir the solution to ensure the capping agent uniformly coats the nanoparticles.

4.4 Washing and Purification

4.4.1 Centrifugation

• 4.4.1.1 Centrifuge the metal nanoparticles to collect them and remove excess salts or reagents.
• 4.4.1.2 Wash the nanoparticles by resuspending them in distilled water and repeating the centrifugation process.

4.5 Characterization

4.5.1 UV-Vis Spectroscopy

• 4.5.1.1 Use UV-Vis spectroscopy to monitor the optical properties of the metal nanoparticles, confirming their formation and size.

4.6 Storage

4.6.1 Storage Conditions

• 4.6.1.1 Store the metal nanoparticles in sterile containers at 4°C or at room temperature, depending on their stability.

5) Abbreviations, if any

• UV-Vis: Ultraviolet-Visible Spectroscopy
• QA: Quality Assurance

6) Documents, if any

• Metal Nanoparticle Synthesis Logbook

7) References, if any

• Material Safety Data Sheets (MSDS) for metal salts and reagents

8) SOP Version

Version 1.0

Annexure

Metal Nanoparticle Synthesis Logbook Template

  

    
Date
    
Batch Number
    
Metal Type
    
Reduction Method
    
Particle Size
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Batch Number
    
Metal (e.g., Gold, Silver)
    
Reduction Method Used (e.g., Chemical, Photochemical)
    
Size in nm
    
Operator Name
    
QA Name
  
  

    
 
    
 
    
 
    
 
    
 
    
 
  

Standard Operating Procedure for Preparation of Nanocrystals for Drug Delivery

1) Purpose

This SOP describes the process for preparing drug nanocrystals, which enhance the solubility and bioavailability of poorly water-soluble drugs. The goal is to standardize the preparation of nanocrystals for drug delivery applications.

2) Scope

This SOP applies to all laboratory staff involved in the formulation and preparation of drug nanocrystals for pharmaceutical and drug delivery purposes.

3) Responsibilities

• Operators: Responsible for following the SOP to prepare nanocrystals according to the specified protocols.
• QA: Ensures compliance with the protocol and verifies the quality of prepared nanocrystals.

4) Procedure

4.1 Preparation of Drug Solution

4.1.1 Drug Selection and Dissolution

• 4.1.1.1 Select the poorly water-soluble drug to be formulated into nanocrystals.
• 4.1.1.2 Dissolve the drug in an organic solvent or a mixture of organic solvents suitable for the nanocrystal formulation.

4.2 Nanocrystal Formation

4.2.1 Precipitation Method

• 4.2.1.1 Add the drug solution dropwise into an aqueous phase containing stabilizers while continuously stirring to precipitate the drug nanocrystals.
• 4.2.1.2 Maintain stirring for 15–30 minutes until nanocrystals are formed.

4.2.2 High-Pressure Homogenization

• 4.2.2.1 Homogenize the suspension at high pressure to reduce the particle size and achieve nanoscale dimensions.
• 4.2.2.2 Monitor the size reduction using dynamic light scattering (DLS) or another particle-sizing method.

4.3 Washing and Collection of Nanocrystals

4.3.1 Filtration

• 4.3.1.1 Filter the nanocrystal suspension using a filtration unit to remove any remaining organic solvents.
• 4.3.1.2 Wash the nanocrystals with distilled water to remove any excess stabilizers or solvents.

4.3.2 Centrifugation

• 4.3.2.1 Centrifuge the suspension to collect the nanocrystals, discarding the supernatant.
• 4.3.2.2 Repeat the washing and centrifugation process as needed to ensure the purity of the nanocrystals.

4.4 Characterization of Nanocrystals

4.4.1 Particle Size Measurement

• 4.4.1.1 Measure the particle size using DLS or other appropriate methods to confirm that the nanocrystals meet the desired size specifications.

4.5 Storage of Nanocrystals

4.5.1 Storage Conditions

• 4.5.1.1 Store the nanocrystals in sterile containers, preferably under refrigeration (4°C) or freeze-drying for long-term stability.

5) Abbreviations, if any

• DLS: Dynamic Light Scattering
• QA: Quality Assurance

6) Documents, if any

• Nanocrystal Preparation Logbook

7) References, if any

• Good Manufacturing Practice (GMP) guidelines for drug formulation

8) SOP Version

Version 1.0

Annexure

Nanocrystal Preparation Logbook Template

  

    
Date
    
Batch Number
    
Drug Name
    
Particle Size
    
Encapsulation Efficiency
    
Operator Initials
    
QA Initials
  
  

    
DD/MM/YYYY
    
Batch Number
    
Drug Name
    
Size in nm
    
% Encapsulation
    
Operator Name
    
QA Name